NORWALK, Conn.--(BUSINESS WIRE)--IMS Health (NYSE: RX), the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced second-quarter 2008 revenue of $600.7 million, up 12 percent or 4 percent on a constant-dollar basis, compared with revenue of $537.5 million for the second quarter of 2007.
